ACC-MESO-1Homo sapiens (Human)Cancer cell line

Also known as: MESO-1, ACCMESO1, ACC-Meso-1

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_5113
SpeciesHomo sapiens (Human)
Tissue SourceLung, pleura[UBERON:UBERON_0000977]

Donor Information

Additional Information
  • No history of asbestos exposure (PubMed=16630136)
Age61
Age CategoryAdult
SexFemale

Disease Information

DiseasePleural mesothelioma
LineagePleura
SubtypePleural Mesothelioma, Epithelioid Type
OncoTree CodePLEMESO

DepMap Information

Source TypeRIKEN
Source IDACH-000086_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleNF2p.Gln389Ter (c.1165C>T)Homozygous-Unknown, PubMed=16630136
Gene deletionCDKN2A-HomozygousPossiblePubMed=26870271

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
8
D16S539
12
D5S818
12
D7S820
10,12
TH01
9
TPOX
11
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

E-cadherin expression is correlated with focal adhesion kinase inhibitor resistance in merlin-negative malignant mesothelioma cells.

Kato T., Sato T., Yokoi K., Sekido Y.

Oncogene 36:5522-5531(2017).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Functional differences between wild-type and mutant-type BRCA1-associated protein 1 tumor suppressor against malignant mesothelioma cells.

Yokoi K., Sekido Y.

Cancer Sci. 106:990-999(2015).

Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.

Asamura H., Gemma A., Yamada T.

J. Thorac. Oncol. 10:844-851(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

LATS2 is a tumor suppressor gene of malignant mesothelioma.";

Sekido Y.

Cancer Res. 71:873-883(2011).

Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.

Sekido Y.

Cancer Sci. 98:438-446(2007).

Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.

Yokoi K., Horio Y., Shimokata K., Sekido Y., Hida T.

Cancer Sci. 97:387-394(2006).